Afecta Pharmaceuticals, Inc.
Major Drugs - Irvine, CA, US
Afecta Pharmaceuticals, Inc. Employees
Afecta Pharmaceuticals, Inc. Details
Afecta Pharmaceuticals, Inc. is a patient-centric, physician driven pharmaceutical company focused on discovering and optimizing small molecules to treat inflammatory diseases. The company has validated its proprietary Artificial Intelligence powered disease/drug targeting platform, PharmetRx™, by discovering and optimizing SPN-810, a drug in development with Supernus Pharmaceuticals (NASDAQ: SUPN). SPN-810 has received FDA Fast Track status and is expected to enter the market in 2019 and reach $1B in revenues at peak. Afecta has now developed a new pipeline of de-risked, small molecule immune- modulating drugs with fast-to-market potential through the FDA 505(b)(2) pathway. Our current internal drug development programs focus on addressing unmet needs in dermatology using several of the drugs we have discovered
Afecta Pharmaceuticals, Inc. Technologies
Email Providers
Outlook
Event Management
Eventbrite
CMS
WordPress.org
Hosted Forms
Wufoo
Other
Mobile Friendly